119 related articles for article (PubMed ID: 37870550)
1. Association of guideline-concordant care with survival, health care utilization, and costs among older women with advanced epithelial ovarian cancer.
Kamat S; Brown BR; Hume A; Vyas A
Am J Manag Care; 2023 Oct; 29(10):e292-e298. PubMed ID: 37870550
[TBL] [Abstract][Full Text] [Related]
2. Association of guideline-concordant initial systemic treatment with clinical and economic outcomes among older women with metastatic breast cancer in the United States.
Vyas A; Mantaian T; Kamat S; Kurian S; Kogut S
J Geriatr Oncol; 2021 Sep; 12(7):1092-1099. PubMed ID: 34099411
[TBL] [Abstract][Full Text] [Related]
3. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
[TBL] [Abstract][Full Text] [Related]
4. Racial disparities in the treatment of advanced epithelial ovarian cancer.
Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
[TBL] [Abstract][Full Text] [Related]
5. Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
Ahmed HZ; Liu Y; O'Connell K; Ahmed MZ; Cassidy RJ; Gillespie TW; Patel P; Pillai RN; Behera M; Steuer CE; Owonikoko TK; Ramalingam SS; Curran WJ; Higgins KA
Clin Lung Cancer; 2017 Nov; 18(6):706-718. PubMed ID: 28601387
[TBL] [Abstract][Full Text] [Related]
6. Health Care Utilization Prior to Ovarian Cancer Diagnosis in Publicly Insured Individuals in New York State.
Gates Kuliszewski M; Boscoe FP; Wagner VL; Schymura MJ
J Registry Manag; 2021; 48(3):126-137. PubMed ID: 35413730
[TBL] [Abstract][Full Text] [Related]
7. Receipt of Guideline-Concordant Care Among Older Women With Stage I-III Breast Cancer: A Population-Based Study.
LeMasters T; Madhavan SS; Sambamoorthi U; Hazard-Jenkins HW; Kelly KM; Long D
J Natl Compr Canc Netw; 2018 Jun; 16(6):703-710. PubMed ID: 29891521
[No Abstract] [Full Text] [Related]
8. Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer.
Simmons D; Blank SV; ElNaggar AC; Chastek B; Bunner SH; McLaurin K
Adv Ther; 2022 Jun; 39(6):2544-2561. PubMed ID: 35362863
[TBL] [Abstract][Full Text] [Related]
9. African American women with advanced-stage ovarian cancer have worse outcomes regardless of treatment type.
Whitmore G; Ramzan A; Sheeder J; Guntupalli SR
Int J Gynecol Cancer; 2020 Jul; 30(7):1018-1025. PubMed ID: 32107316
[TBL] [Abstract][Full Text] [Related]
10. Receipt of Guideline-Concordant Care Does Not Explain Breast Cancer Mortality Disparities by Race in Metropolitan Atlanta.
Collin LJ; Yan M; Jiang R; Gogineni K; Subhedar P; Ward KC; Switchenko JM; Lipscomb J; Miller-Kleinhenz J; Torres MA; Lin J; McCullough LE
J Natl Compr Canc Netw; 2021 Aug; 19(11):1242-1251. PubMed ID: 34399407
[TBL] [Abstract][Full Text] [Related]
11. Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancer.
Aviki EM; Lavery JA; Roche KL; Cowan R; Dessources K; Basaran D; Green AK; Aghajanian CA; O'Cearbhaill R; Jewell EL; Leitao MM; Gardner GJ; Abu-Rustum NR; Sabbatini P; Bach PB
Gynecol Oncol; 2020 Nov; 159(2):418-425. PubMed ID: 32814642
[TBL] [Abstract][Full Text] [Related]
12. Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States.
Huepenbecker SP; Sun CC; Fu S; Zhao H; Primm K; Rauh-Hain JA; Fleming ND; Giordano SH; Meyer LA
Int J Gynecol Cancer; 2022 Sep; 32(9):1153-1163. PubMed ID: 36166208
[TBL] [Abstract][Full Text] [Related]
13. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
[TBL] [Abstract][Full Text] [Related]
14. Adherence to Guideline-Concordant Care and Its Effect on Survival in Black Patients with Head and Neck Cancers: A SEER-Medicare Analysis.
Vyfhuis MAL; Suzuki I; Bentzen SM; Cullen KJ; Goloubeva OG
Oncologist; 2021 Jul; 26(7):579-587. PubMed ID: 33783061
[TBL] [Abstract][Full Text] [Related]
15. Impact of Guideline-Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early-Stage Breast Cancer.
Williams CP; Kenzik KM; Azuero A; Williams GR; Pisu M; Halilova KI; Ingram SA; Yagnik SK; Forero A; Bhatia S; Rocque GB
Oncologist; 2019 Jan; 24(1):31-37. PubMed ID: 30120157
[TBL] [Abstract][Full Text] [Related]
16. Healthcare Access Dimensions and Guideline-Concordant Ovarian Cancer Treatment: SEER-Medicare Analysis of the ORCHiD Study.
Montes de Oca MK; Wilson LE; Previs RA; Gupta A; Joshi A; Huang B; Pisu M; Liang M; Ward KC; Schymura MJ; Berchuck A; Akinyemiju TF
J Natl Compr Canc Netw; 2022 Nov; 20(11):1255-1266.e11. PubMed ID: 36351338
[TBL] [Abstract][Full Text] [Related]
17. Trends in the receipt of guideline care and survival for women with ovarian cancer: A population-based study.
Warren JL; Harlan LC; Trimble EL; Stevens J; Grimes M; Cronin KA
Gynecol Oncol; 2017 Jun; 145(3):486-492. PubMed ID: 28372872
[TBL] [Abstract][Full Text] [Related]
18. Impact of Nonconcordance With NCCN Guidelines on Resource Utilization, Cost, and Mortality in De Novo Metastatic Breast Cancer.
Rocque GB; Williams CP; Jackson BE; Ingram SA; Halilova KI; Pisu M; Kenzik KM; Azuero A; Forero A; Bhatia S
J Natl Compr Canc Netw; 2018 Sep; 16(9):1084-1091. PubMed ID: 30181420
[No Abstract] [Full Text] [Related]
19. Disparities in hospice care among older women dying with ovarian cancer.
Fairfield KM; Murray KM; Wierman HR; Han PK; Hallen S; Miesfeldt S; Trimble EL; Warren JL; Earle CC
Gynecol Oncol; 2012 Apr; 125(1):14-8. PubMed ID: 22138230
[TBL] [Abstract][Full Text] [Related]
20. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
